Login / Signup

Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation.

Ling LiJannah BakerRenee QuirkDanielle DeidunMaria MoranAhmed Abo SalemNanda AryalBethany Annemarie Van DortWu Yi ZhengAndrew HargreavesPaula DohertySarah Nicole HilmerRichard Osborne DayJohanna I WestbrookMelissa Therese Baysari
Published in: Drug safety (2024)
Although most patients experienced a pDDI during their hospital stay, less than one-third of pDDIs were clinically relevant. The low prevalence of harm identified raises questions about the value of incorporating DDI decision support into systems given the potential negative impacts of DDI alerts.
Keyphrases
  • healthcare
  • end stage renal disease
  • risk factors
  • adverse drug
  • newly diagnosed
  • chronic kidney disease
  • primary care
  • prognostic factors
  • emergency department
  • quality improvement